110 related articles for article (PubMed ID: 3754997)
1. The metabolic disposition of 14C-ciramadol in humans.
Sisenwine SF; Liu AL; Tio C; Kimmel H; Freeland G
Xenobiotica; 1986 Apr; 16(4):335-40. PubMed ID: 3754997
[TBL] [Abstract][Full Text] [Related]
2. Metabolic disposition of ciramadol in rhesus monkeys and rats.
Sisenwine SF; Tio CO; Ruelius HW
Drug Metab Dispos; 1982; 10(2):161-7. PubMed ID: 6124403
[TBL] [Abstract][Full Text] [Related]
3. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
4. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of ciramadol glucuronidation by benzodiazepines.
Meacham RH; Sisenwine SF; Liu AL; Kick CJ; Barinov I; Ruelius HW
Drug Metab Dispos; 1986; 14(4):430-6. PubMed ID: 2873990
[TBL] [Abstract][Full Text] [Related]
6. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog.
Wood SG; John BA; Chasseaud LF; Bonn R; Grote H; Sandrock K; Darragh A; Lambe RF
Xenobiotica; 1987 Jul; 17(7):881-96. PubMed ID: 3660858
[TBL] [Abstract][Full Text] [Related]
7. Preliminary pharmacokinetics of intravenous ciramadol in humans.
Rosseel MT; Bogaert MG; Oosterlinck W
Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):304-6. PubMed ID: 6547699
[TBL] [Abstract][Full Text] [Related]
8. Physiological disposition and metabolic fate of a new antiarrhythmic agent, alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine in the rat, dog, monkey, baboon, and man.
Zacchei AG; Weidner LL; Besselaar GH; Raftery EB
Drug Metab Dispos; 1976; 4(4):387-401. PubMed ID: 8295
[TBL] [Abstract][Full Text] [Related]
9. The disposition and metabolic fate of 14C-cibenzoline in man.
Massarella JW; Loh AC; Williams TH; Szuna AJ; Sandor D; Bressler R; Leinweber FJ
Drug Metab Dispos; 1986; 14(1):59-64. PubMed ID: 2868867
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and kinetics of amlodipine in man.
Beresford AP; McGibney D; Humphrey MJ; Macrae PV; Stopher DA
Xenobiotica; 1988 Feb; 18(2):245-54. PubMed ID: 2967593
[TBL] [Abstract][Full Text] [Related]
11. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
[TBL] [Abstract][Full Text] [Related]
12. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
[TBL] [Abstract][Full Text] [Related]
13. The disposition of [14C]-labelled benazepril HCl in normal adult volunteers after single and repeated oral dose.
Waldmeier F; Kaiser G; Ackermann R; Faigle JW; Wagner J; Barner A; Lasseter KC
Xenobiotica; 1991 Feb; 21(2):251-61. PubMed ID: 2058180
[TBL] [Abstract][Full Text] [Related]
14. Disposition of bemitradine, a renal vasodilator and diuretic, in man.
Walls CM; Gray A; Vose CW; Robinson Y; Lopez N; Brownsill RD; Steiner JA
Xenobiotica; 1988 Dec; 18(12):1413-23. PubMed ID: 3245233
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of ethynodiol diacetate in the rhesus monkey before and after administration of rifampicin.
Lewis CJ; Vose CW; Spalton PN; Ford GC; Haskins NJ; Palmer RF
Xenobiotica; 1980 Sep; 10(9):705-13. PubMed ID: 7445531
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys.
Siefert HM; Maruhn D; Maul W; Förster D; Ritter W
Arzneimittelforschung; 1986 Oct; 36(10):1496-502. PubMed ID: 3814211
[TBL] [Abstract][Full Text] [Related]
17. Disposition and metabolism of finasteride in dogs.
Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ
Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636
[TBL] [Abstract][Full Text] [Related]
18. Absorption, metabolism, and excretion of paliperidone, a new monoaminergic antagonist, in humans.
Vermeir M; Naessens I; Remmerie B; Mannens G; Hendrickx J; Sterkens P; Talluri K; Boom S; Eerdekens M; van Osselaer N; Cleton A
Drug Metab Dispos; 2008 Apr; 36(4):769-79. PubMed ID: 18227146
[TBL] [Abstract][Full Text] [Related]
19. The disposition and metabolism of [14C]fluconazole in humans.
Brammer KW; Coakley AJ; Jezequel SG; Tarbit MH
Drug Metab Dispos; 1991; 19(4):764-7. PubMed ID: 1680653
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of labetalol by animals and man.
Martin LE; Hopkins R; Bland R
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
